SUMMARY Immune complexes were measured in the sera of 18 patients with ankylosing spondylitis and 5 normal control subjects by their ability to inhibit antibody-mediated lymphocyte-induced cytotoxicity. 11 of the spondylitic and none of the control sera contained circulating complexes. Fractionation of sera on and Triosil-Ficoll purified human peripheral blood lymphocytes (lymphocyte/target cell ratio 30/1) for 4 hours at 37°C. The inhibition of cytotoxicity by sera from normal subjects, patients with AS, or aggregated human IgG (aggregated by heating (HAGG) at 63°C for 20 min) was expressed as: % inhibition = % cytotoxicity in control medium % cytotoxicity in serum or HAGG % cytotoxicity in control medium Since the inflammatory changes in AS are not confined to the sacroiliac and vertebral joints but may also affect peripheral joints, the aortic valve, and the uveal tract, circulating immune complexes may be present. This work detected and measured circulating immune complexes in AS by the inhibition of antibody-mediated lymphocyte-induced cytotoxicity (AMLC).
Although the aetiology of ankylosing spondylitis (AS) is unknown, there is increasing evidence that immunological mechanisms may be involved. Among this evidence may be included (1) hypergammaglobulinaemia and abnormalities of serum complement (Kinsella et al., 1975) ; (2) the presence of IgG anti-immunoglobulins in serum (Arana et al., 1975) ; and (3) the association between AS and HLA B27 histocompatibility antigen (Brewerton et al., 1973) , which may imply that an immune response gene may be active in the disease. (Panayi et al., 1977) . In brief, Chang human liver cells (Flow Laboratories) were labelled with 51Cr-sodium chromate (Radio Chemical Centre, Amersham), and incubated with rabbit anti-Chang antiserum (final dilution and Triosil-Ficoll purified human peripheral blood lymphocytes (lymphocyte/target cell ratio 30/1) for 4 hours at 37°C. The inhibition of cytotoxicity by sera from normal subjects, patients with AS, or aggregated human IgG (aggregated by heating (HAGG) at 63°C for 20 min) was expressed as: % inhibition = % cytotoxicity in control medium % cytotoxicity in serum or HAGG % cytotoxicity in control medium Since the inflammatory changes in AS are not confined to the sacroiliac and vertebral joints but may also affect peripheral joints, the aortic valve, and the uveal tract, circulating immune complexes may be present. This work detected and measured circulating immune complexes in AS by the inhibition of antibody-mediated lymphocyte-induced cytotoxicity (AMLC).
Materials and methods

THE CYTOTOXIC SYSTEM
This system has been described in detail elsewhere Accepted for publication August 24, 1977 Correspondence to Dr G. S. Panayi x 100.
The per cent inhibition of cytotoxicity produced by a particular serum was compared to the inhibition produced by HAGG in parallel and simultaneous experiments so that results of inhibition were expressed as ',tg/ml of HAGG equivalents'. In every experiment normal and AS sera were included.
PATIENTS AND SERA
Eighteen patients with AS (all having HLA B27 histocompatibility antigen) and 5 control subjects were studied. Sera were separated within 3 hours of bleeding and stored in 0-5 ml aliquots in liquid nitrogen. Preliminary experiments showed that storage of serum at -20°C generated inhibiting activity probably because of formation of aggregates of IgG. Sera were tested within one month. Aliquots of serum were thawed once and used on the same day.
CHROMATOGRAPHY OF SERA Sera were fractionated on a 100 cm x 2-5 cm column of at an elution rate of 14 ml/h with collection of20-minute fractions.
The optical density (E1280cm) of fractions was read on a Perkin-Elmer spectrophotometer. The elution buffer was phosphate-buffered saline, pH 7-2, containing 0.05% sodium azide. While 0-5 ml of a particular serum was being fractionated, another 0 5 ml was diluted to 2 5 ml with elution buffer and stood at room temperature in order to control the changes due to thawing, buffer dilution, and temperature changes which the fractionated aliquot would undergo during elution. At the end ofchromography, designated fractions and the diluted aliquot were concentrated back to 0-5 ml by Amicon 'centriflo' membrane concentration before being tested for their ability to inhibit AMLC.
Sera and their chromatographic fractions were tested for inhibition of AMLC at a dilution of 1:10.
CALIBRATION OF SEPHADEX G-200 COLUMN
The column was calibrated with the following substances: human serum albumin (70 000 daltons), human IgG (160 000 daltons), carcinoembryonic antigen (200 000 daltons), and human rgM (1 000 000 daltons). group.bmj.com on June 24, 2017 -Published by http://ard.bmj.com/ Downloaded from remaining 3 sera had elution profiles different from and distributed in two peaks (Fig. lb, c, d ). When all the other sera ( Fig. la) (Hansson, 1968) , the absence of inhibiting activity (280 nm) and the presence of immune complexes was before and after storage in control sera and some measured. The column was calibrated with IgM, IgG, sera of patients with AS renders this unlikely.
HSA (human serum albumin), and CEA (carcino-(2) Dilution of sera with elution buffer and conembryonic antigen). (a) Profile of eluted proteins: centration of chromatographic fractions by Amicon for 5 control and 2 AS sera with no immune complexes ultrafiltration is unlikely to have generated inhibiting and for one AS serum with complexes; ------for activity since those sera which did not show inhibiremaining 3 AS sera which contained complexes showing tion before such manipulations did not do so increased eluted protein in fractions 35-40 inclusive. We therefore conclude that some two-thirds of patients with AS carry circulating immune complexes in their serum. These complexes seem to be of two molecular sizes: one of intermediate molecular weight (2 2 x 105 -106 daltons) and one of large molecular weight (>106 daltons). Previous work with this system seemed to indicate that it is most sensitive in detecting complexes of intermediate size (Jewell and MacLennan, 1973) , but clearly it is also capable of detecting larger molecular weight complexes.
One finding requires explanation. (Fig. 2) . Nevertheless, this study shows that circulating immune complexes are indeed present in the serum of patients with AS.
Two aspects of this new observation remain to be explained. The first concerns the poor correlation between disease activity and presence of circulating complexes, although one patient with inflammatory peripheral arthritis had the highest concentration of complexes seen in this study. It may be that this failure was due to the relative paucity of extraspinal systemic complications in the group of patients investigated. The difficulty of objectively measuring disease activity may also have contributed to this failure.
The second aspect concerns the nature of the circulating complexes present in serum and in particular the identity of the antigen which they contain. In AS patients IgG antiglobulin factors are found (Arana et al., 1975) . It is known that such antiglobulins may self-associate to form complexes capable of activating the complement system and hence capable of initiating inflammation (Winchester et al., 1970; Pope et al., 1975) . From this point of view, therefore, they may be similarities in immunopathogenesis between AS and rheumatoid arthritis. This is supported by family studies of lymphocyte responsiveness to IgG in the two diseases (Weisbart et al., 1976 ). 
